265 related articles for article (PubMed ID: 30319642)
1. Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity.
Corapi E; Carrizo G; Compagno D; Laderach D
Front Immunol; 2018; 9():2190. PubMed ID: 30319642
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis.
Caputo S; Grioni M; Brambillasca CS; Monno A; Brevi A; Freschi M; Piras IS; Elia AR; Pieri V; Baccega T; Lombardo A; Galli R; Briganti A; Doglioni C; Jachetti E; Bellone M
Front Immunol; 2020; 11():1820. PubMed ID: 33013832
[TBL] [Abstract][Full Text] [Related]
3. A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.
Laderach DJ; Gentilini LD; Giribaldi L; Delgado VC; Nugnes L; Croci DO; Al Nakouzi N; Sacca P; Casas G; Mazza O; Shipp MA; Vazquez E; Chauchereau A; Kutok JL; Rodig SJ; Elola MT; Compagno D; Rabinovich GA
Cancer Res; 2013 Jan; 73(1):86-96. PubMed ID: 23108139
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 fosters an immunosuppressive microenvironment in colorectal cancer by reprogramming CD8
Cagnoni AJ; Giribaldi ML; Blidner AG; Cutine AM; Gatto SG; Morales RM; Salatino M; Abba MC; Croci DO; Mariño KV; Rabinovich GA
Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34006646
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive Roles of Galectin-1 in the Tumor Microenvironment.
Huang Y; Wang HC; Zhao J; Wu MH; Shih TC
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680031
[TBL] [Abstract][Full Text] [Related]
6. Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.
Tiraboschi C; Gentilini L; Velazquez C; Corapi E; Jaworski FM; Garcia Garcia JD; Rondón Y; Chauchereau A; Laderach DJ; Compagno D
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33293356
[TBL] [Abstract][Full Text] [Related]
7. A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma.
Liebscher L; Weißenborn C; Langwisch S; Gohlke BO; Preissner R; Rabinovich GA; Christiansen N; Christiansen H; Zenclussen AC; Fest S
Cancer Lett; 2021 Jul; 509():105-114. PubMed ID: 33848518
[TBL] [Abstract][Full Text] [Related]
8.
Jaworski FM; Gentilini LD; Gueron G; Meiss RP; Ortiz EG; Berguer PM; Ahmed A; Navone N; Rabinovich GA; Compagno D; Laderach DJ; Vazquez ES
Clin Cancer Res; 2017 Sep; 23(17):5135-5148. PubMed ID: 28512172
[No Abstract] [Full Text] [Related]
9. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms.
Poncini CV; Ilarregui JM; Batalla EI; Engels S; Cerliani JP; Cucher MA; van Kooyk Y; González-Cappa SM; Rabinovich GA
J Immunol; 2015 Oct; 195(7):3311-24. PubMed ID: 26324777
[TBL] [Abstract][Full Text] [Related]
10. Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation.
Cedeno-Laurent F; Barthel SR; Opperman MJ; Lee DM; Clark RA; Dimitroff CJ
J Immunol; 2010 Oct; 185(8):4659-72. PubMed ID: 20844192
[TBL] [Abstract][Full Text] [Related]
11. Galectin-1 is a local but not systemic immunomodulatory factor in mesenchymal stromal cells.
Fajka-Boja R; Urbán VS; Szebeni GJ; Czibula Á; Blaskó A; Kriston-Pál É; Makra I; Hornung Á; Szabó E; Uher F; Than NG; Monostori É
Cytotherapy; 2016 Mar; 18(3):360-70. PubMed ID: 26857229
[TBL] [Abstract][Full Text] [Related]
12. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege.
Rubinstein N; Alvarez M; Zwirner NW; Toscano MA; Ilarregui JM; Bravo A; Mordoh J; Fainboim L; Podhajcer OL; Rabinovich GA
Cancer Cell; 2004 Mar; 5(3):241-51. PubMed ID: 15050916
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity.
Sturgill ER; Rolig AS; Linch SN; Mick C; Kasiewicz MJ; Sun Z; Traber PG; Shlevin H; Redmond WL
Oncoimmunology; 2021 Mar; 10(1):1892265. PubMed ID: 33717655
[TBL] [Abstract][Full Text] [Related]
14. Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategy.
Van Woensel M; Mathivet T; Wauthoz N; Rosière R; Garg AD; Agostinis P; Mathieu V; Kiss R; Lefranc F; Boon L; Belmans J; Van Gool SW; Gerhardt H; Amighi K; De Vleeschouwer S
Sci Rep; 2017 Apr; 7(1):1217. PubMed ID: 28450700
[TBL] [Abstract][Full Text] [Related]
15. Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy.
Anker JF; Naseem AF; Mok H; Schaeffer AJ; Abdulkadir SA; Thumbikat P
Nat Commun; 2018 Apr; 9(1):1591. PubMed ID: 29686284
[TBL] [Abstract][Full Text] [Related]
16. Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells.
Perone MJ; Larregina AT; Shufesky WJ; Papworth GD; Sullivan ML; Zahorchak AF; Stolz DB; Baum LG; Watkins SC; Thomson AW; Morelli AE
J Immunol; 2006 Jun; 176(12):7207-20. PubMed ID: 16751364
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Galectin-1 Tumor Microenvironment in Radiosensitivity.
Chen YF; Wang CC; Hsu CY; Huang EY
Anticancer Res; 2021 May; 41(5):2321-2331. PubMed ID: 33952457
[TBL] [Abstract][Full Text] [Related]
18. Silencing the expression of Cbl-b enhances the immune activation of T lymphocytes against RM-1 prostate cancer cells in vitro.
Zhou SK; Chen WH; Shi ZD; Wang SP; Li L; Wen XF; Wang YM
J Chin Med Assoc; 2014 Dec; 77(12):630-6. PubMed ID: 25249301
[TBL] [Abstract][Full Text] [Related]
19. Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis.
Banh A; Zhang J; Cao H; Bouley DM; Kwok S; Kong C; Giaccia AJ; Koong AC; Le QT
Cancer Res; 2011 Jul; 71(13):4423-31. PubMed ID: 21546572
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of intracellular galectin-1-expressing lymphocytes in umbilical cord blood in comparison with adult peripheral blood.
Kollár S; Sándor N; Molvarec A; Stenczer B; Rigó J; Tulassay T; Vásárhelyi B; Toldi G
Biol Blood Marrow Transplant; 2012 Oct; 18(10):1608-13. PubMed ID: 22609846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
